ZYME
ZYME
NASDAQ · Biotechnology

Zymeworks Inc

$24.02
+0.70 (+3.00%)
As of Mar 23, 10:02 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -25.6% upside
Low Target $12.55
Average Target $17.86
High Target $20.90
Current Price $24.02
Current
$24.02
Target
$17.86
$12.55 $17.86 avg $20.90
Scenario Analysis
Bear Case
$12.55
-47.8%
Low target
Base Case
$17.86
-25.6%
Avg target
Bull Case
$20.90
+-13.0%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$28.49
-15.7% from high
52-Week Low
$9.03
+166.0% from low
Target vs 52W High
$17.86
-37.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%